| ENDRA Life Sciences is engaged in developing technology in clinical diagnostic ultrasound for patient access to the diagnosis and treatment of various medical conditions. Co.'s Thermo-Acoustic Enhanced Ultrasound (TAEUS) technology uses a pulsed energy source, radio-frequency, to generate ultrasonic waves in tissue. These waves are then detected with ultrasound equipment and used to create images and other forms of data using its proprietary algorithms. Co. is also developing TAEUS for incorporation into new ultrasound systems manufactured by companies such as General Electric Company, acting through its GE Healthcare business unit and the GE Global Research Center. We show 17 historical shares outstanding datapoints in our coverage of NDRA's shares outstanding history.|
Understanding the changing numbers of NDRA shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like NDRA versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching NDRA by allowing them to research NDRA shares outstanding history
as well as any other stock in our coverage universe.